A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.
- DOI
- 10.1177/20420188261480984
- Published
- 2026
- Container
- Therapeutic advances in endocrinology and metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/20420188261480984,
title = {A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.},
author = {Dauber A and Savarirayan R and Carroll R and Cheung M and Cormier-Daire V and Maghnie M and Namba N and Semler O and Ghani S and Sabir I and Bassi R},
year = {2026},
journal = {Therapeutic advances in endocrinology and metabolism},
doi = {10.1177/20420188261480984},
url = {https://doi.org/10.1177/20420188261480984}
}RIS
TY - JOUR TI - A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design. AU - Dauber A AU - Savarirayan R AU - Carroll R AU - Cheung M AU - Cormier-Daire V AU - Maghnie M AU - Namba N AU - Semler O AU - Ghani S AU - Sabir I AU - Bassi R PY - 2026 JO - Therapeutic advances in endocrinology and metabolism DO - 10.1177/20420188261480984 UR - https://doi.org/10.1177/20420188261480984 ER -
APA
A, D., R, S., R, C., M, C., V, C., M, M., N, N., O, S., S, G., I, S., & R, B. (2026). A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.. Therapeutic advances in endocrinology and metabolism. https://doi.org/10.1177/20420188261480984
Source records
- pubmed · retrieved 2026-09-27T09:52:11.925Z